The Good
A good signal, yielding acceptable resolution of positive versus negative cells
The Bad
As an ECD conjugate, spillover/spread becomes an issue
The Bottom Line
This antibody is a good anti-CD19 reagent, that is also ASR which is preferable in clinical trials. Compensation can be an issue, and must be done properly.